» Articles » PMID: 25774093

Transient Knockdown-mediated Deficiency in Plectin Alters Hepatocellular Motility in Association with Activated FAK and Rac1-GTPase

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2015 Mar 17
PMID 25774093
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Plectin is one of the cytolinker proteins that play a crucial role in maintaining the integrity of cellular architecture. It is a component of desmosome complexes connecting cytoskeletal proteins and trans-membrane molecules. In epithelial cells, plectin connects cytokeratins and integrin α6β4 in hemidesmosomes anchoring to the extracellular matrix. In addition to the function of molecular adherent, plectin has been reported to exhibit functions affecting cellular signals and responsive activities mediated by stress, cellular migration, polarization as well as the dynamic movement of actin filaments. Plectin deficiency in hepatocellular carcinoma results in abnormal expression of cytokeratin 18 and disassembled hemidesmosome. Therefore, it is hypothesized that the plectin deficiency-mediated collapse of cytoskeleton may modulate cellular motility that is associated with consequent metastatic behaviors of cancer cells.

Methods And Results: The cellular motility of plectin-deficient Chang liver cells generated by transient knockdown were analyzed by trans-well migration assay and the results revealed a higher migration rate. The confocal microscopy also demonstrated less organized and more polarized morphology as well as more focal adhesion kinase activity in comparison with that of the mock Chang liver cells. Furthermore, plectin-knockdown in Chang liver cells was associated with a higher activity of Rac1-GTPase in accordance with the results of the Rac1 pull-down assay. The immunohistochemical assay on human hepatocellular carcinoma showed that the expression of focal adhesion kinase was increased in the invasive front of tumor.

Conclusion: Plectin-deficient human hepatic cells exhibit higher cell motility associated with increase in focal adhesion kinase activity that are comparable to the properties of invasive hepatocellular carcinoma.

Citing Articles

Plectin: Dual Participation in Tumor Progression.

Wang Z, Wang W, Luo Q, Song G Biomolecules. 2024; 14(9).

PMID: 39334817 PMC: 11430127. DOI: 10.3390/biom14091050.


Epiplakin expression dynamics during colon carcinogenesis: Correlation with proliferation.

Findik D, Sahin E, Turelik O, Guneri G Biomol Biomed. 2024; 25(1):62-70.

PMID: 39052015 PMC: 11647249. DOI: 10.17305/bb.2024.10981.


Role of plectin and its interacting molecules in cancer.

Gao K, Gao Z, Xia M, Li H, Di J Med Oncol. 2023; 40(10):280.

PMID: 37632650 DOI: 10.1007/s12032-023-02132-4.


Plectin in Cancer: From Biomarker to Therapeutic Target.

Perez S, Brinton L, Kelly K Cells. 2021; 10(9).

PMID: 34571895 PMC: 8469460. DOI: 10.3390/cells10092246.


The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence.

Wesley T, Berzins S, Kannourakis G, Ahmed N Cell Commun Signal. 2021; 19(1):55.

PMID: 34001250 PMC: 8127266. DOI: 10.1186/s12964-021-00726-x.


References
1.
Webb D, Parsons J, Horwitz A . Adhesion assembly, disassembly and turnover in migrating cells -- over and over and over again. Nat Cell Biol. 2002; 4(4):E97-100. DOI: 10.1038/ncb0402-e97. View

2.
Rezniczek G, de Pereda J, Reipert S, Wiche G . Linking integrin alpha6beta4-based cell adhesion to the intermediate filament cytoskeleton: direct interaction between the beta4 subunit and plectin at multiple molecular sites. J Cell Biol. 1998; 141(1):209-25. PMC: 2132717. DOI: 10.1083/jcb.141.1.209. View

3.
Cheng C, Liu Y, Ho C, Chao W, Pei R, Hsu Y . The influence of plectin deficiency on stability of cytokeratin18 in hepatocellular carcinoma. J Mol Histol. 2007; 39(2):209-16. DOI: 10.1007/s10735-007-9155-9. View

4.
Lightfoot Jr H, Lark A, Livasy C, Moore D, Cowan D, Dressler L . Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. Breast Cancer Res Treat. 2004; 88(2):109-16. DOI: 10.1007/s10549-004-1022-8. View

5.
Osmanagic-Myers S, Wiche G . Plectin-RACK1 (receptor for activated C kinase 1) scaffolding: a novel mechanism to regulate protein kinase C activity. J Biol Chem. 2004; 279(18):18701-10. DOI: 10.1074/jbc.M312382200. View